Renaissance Technologies - CNS PHARMACEUTICALS INC ownership

CNS PHARMACEUTICALS INC's ticker is CNSP and the CUSIP is 18978H102. A total of 21 filers reported holding CNS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CNS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$10,000
-94.2%
56,800
-88.8%
0.00%
Q1 2022$173,000
+66.3%
506,532
+242.9%
0.00%
Q4 2021$104,000
-87.7%
147,700
-65.8%
0.00%
-100.0%
Q2 2021$847,000
-51.0%
432,109
-40.2%
0.00%
-50.0%
Q1 2021$1,727,000722,7600.00%
Other shareholders
CNS PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Virtu Financial LLC 20,745$41,0000.00%
Integrated Advisors Network LLC 10,700$21,0000.00%
Alpha Cubed Investments, LLC 11,000$22,0000.00%
Renaissance Technologies 432,109$847,0000.00%
TWO SIGMA SECURITIES, LLC 11,061$22,0000.00%
Sterling Financial Planning, Inc. 600$1,0000.00%
UBS Group AG 4,676$9,0000.00%
Capital Analysts, LLC 1,000$2,0000.00%
OSAIC HOLDINGS, INC. 5,000$10,0000.00%
BANK OF AMERICA CORP /DE/ 2,000$4,0000.00%
View complete list of CNS PHARMACEUTICALS INC shareholders